Skip to: Content
Skip to: Site Navigation
Skip to: Search

November 21, 2008 7:16:02 PM CST



Heparin Supply Chain Shaky in China

Posted Feb 28, 08 2:07 PM CST in Business World 

(Newser) – With at least four US patients dead and hundreds suffering complications from the blood-thinning drug heparin, the New York Times follows the supply chain back to Chinese slaughterhouses that deal with the pig intestines that provide raw material for the drug. Though companies say the chain is secure, the Times finds it vulnerable to contamination and lack of oversight.

American investigators are trying to determine where in the process the crude heparin, refined from pig intestines, is being contaminated. Heparin-maker Baxter International has stopped producing multi-dose vials of the drug while investigators audit the records of a US company’s Chinese subsidiary, Changzhou SPL, which collects and refines the raw material.

Source New York Times

0 comments | Print E-mail | Digg Seed this on Newsvine Add this link to Del.icio.us StumbleUpon
Chinese workers watch a pharmaceutical production line at a Beijing factory.   (Getty Images)
A Chinese pharmaceutical worker holds vials of medicine.   (Getty Images)
« Prev« Prev | Next »Next » Slideshow
Our editors also recommend:

Threads (
1
 of 2)



Loading...

Premium Articles from HighBeam

Find more articles like this

Today's Most Popular

Loading...

Other World Stories


What is Newser?

2008 Codie Finalist

Face it: there's too much news. At Newser a team of editors and writers culls the most important stories from hundreds of U.S. and international sources and reduces them to a headline, picture, and two paragraphs. It's the Newser guarantee: we can take any report or column or video and pack what you need to know into 120 words or less. Newser's short-form aggregation, visual format, and unique information tools help you get more of the kind of news you want, in a quicker and more entertaining way. And we do it 24/7—you can come back morning, noon, night (and in between) for something new that matters. Read less, know more.

Learn more »